ABCL- Big Move PendingFrom a technical perspective, the last time we saw a golden cross, was in early 2023, that is nearly 2 years ago.
Nice upside potential pending
ABCL trade ideas
ABCL - +40% upside with 1:3 RRSet-up nicely after a squeeze for a breakout and a mean reversion to the fibonacci retracement areas.
My target is 0.50 which is $4.24
However, based on analyst ratings the stock could do 400% in the next 12 months.
$ABCL - bull flag in the making?A potential bull flag formation in the making for $ABCL. Volume drying up in the flag part of the channel. Would love to see this breakout above $6.
$ABCL get ready for liftoff NASDAQ:ABCL could blow through the light volume gap and return back to the high 6s, low 7s. With AI hype coming back, this might a good time to add to or start a position.
Three soldiers I remember reading somewhere about chart patterns...this is one of them. 3 rising volume spikes indicating a shift in momentum. ABCL is forecast for major growth...I have taken a position here. Would have been great to grab the bottom if you had the confidence!
3 stocks to buy nowABCL, TGNA and BOXL are showing great entries for long term investments that may provide more than 300% return. Interest rate cuts may accelerate the process.
$ABCL a favorite long term but risk ahead$ABCL a favorite long term but risk ahead if markets falter as revenue from Covid treatment stops coming in
ABCL - Cup & Handle Breakout TradeAbcellera Biologics is a biotech stock setting up in a textbook cup with handle pattern.
The stock has growing institutional sponsorship as shown in the chart from MarketSmith on the chart. It also has a relative strength ranking of 97/100.
Shares formed a cup with a 37% depth and have since drifted back slightly to form a defined handle.
I will consider buying on a break above the dashed downtrend line of the handle.
ABCL - Tight bullish flasNice secondary entry to add to your position.
After breaking out of the previous flag, price consolidated again for almost a week on decling volume.
Enter the stock if it moves over the high from the previous day.
Stoploss can be set at the low of the previous day (tight stop loss) or underneath the rising trend line (loose stop loss)
In a longer term perspective the $15-16 area is a place of congestion and price could rally to this area before taking another breather. The 10 and 30 week MA's are also a bit far so price could get extended when entering this zone.
This stock is already in a stage 2 (Weinstein), so could deserve a place in your LT portfolio.
Increase in inst. owernship.
ABCL Possible Stage 2?I'm a novice learning The Man's ways. My crayon drawing on this chart appears to be a close to a Stage 2 breakout. I think. Since ABCL is a yungun' I substituted the 150 for the 50.
Anyone else have an opinion?
XBI looks like a current leading sector.
I still feel its early but I just do what the chart is telling me... or technically the book is telling me what the chart is telling me. Is this a debt spiral?????
Good fundamentals + Breakout ✨Hey Guys, Yurii Domaranskyi here.
Risk vs Reward = 1 to 5.74 ✨
It means if you risk here 1000$ you may make 5740$ Not bad, huh?
WAIT FOR THE PULLBACK I see a long bearish trend making its fifth wave (elliot wave). wyckoff accumulation become more and more relevant, stop hunt followed by a break of market structure already happened;
I marked 3 zones in wich the pullback may stop
Watch $ABCL Potential Inverse H&S formationBullish
- Stage 1
- Decent sector position within 50%
- No longer making lower lows on the weekly
- Broke out of downward trend line
- Potential inverse H&S formation
- Gaining momentum on the upside seen on the Momentum Theory Indicator
- Smart money have been accumulating
- Decent sales
Bearish
- Great if better P/FCF ratio
- Great if lower PEG ratio
- Bearish macro environment
Entry trigger : For members only
ABCL (Abcellera Biologics) is due for a breakout soon Double Bottom
W formation in process
Divergence Stoch
Lots of buying in effect since bottomming
9 EMA and 21 EMA rising, stock rising with 9 EMA
AbCellera Biologics (Long hold)AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, Artificial Intelligence-powered drug discovery platform integrates modern technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce costs, and tackle the toughest problems in drug development.
Imagine a world where artificial intelligence could find the cure to any disease. That's what this company is all about.
the chart might not be the prettiest, but their mission is one I am willing to invest in.
-------
$37 is my conservative target from the current levels, and it's very possible we make a few more lower lows, but ultimately I think this company has a very bright future despite the recent beat downs.
If and when we reach $37, I'd like to re-evaluate my analysis, & deep dive into the wave structure which brought us there. If it looks clean, then new projections can be made.
💸
ABCL seems that it might be makinb a (v) of a CABCL looks like is finishing a 3 waves downside move, price action seems to be contained within parallel lines, price could come down to 9,51$ and from the we could see a bounce to the upside and start a new trend and resume the downtrend.
Bullish long term but bearish in shortGreat company of they achieve their goals this one might shake the bio sector, i believe in their CEO and investing some in their dreams ...
if we get any positive news from merck pills from FDA we might go to $10 range and if not we will go back to +$20 however this is not covid play for me in long term
AbCellera: $15 | a Gem under the radar should be the next crispr or illumina ... it supplies stuff to MODERNA
it could be the secret sauce in pre diagnotics or preventing diseases before they become serious
currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
Long ABCLThis is a technical analysis setup:
1) The moving average crossed over signaling buy after a bottoming at at around $15.50
2) I am targeting the first missed pivot $23.30
Based on the close today this would be a 34% return with limited downside.
Regards,
ABCL - 20-30% UPSIDE - LONGAll,
ABCL is for massively oversold on weekly down so regardless how you feel about the stock (even though price target analysts are WAY higher) this is due for a rip. Not to mention this is a perfect situation for institutions to enter into ABCL at a pretty big discount from fair value etc.
I am temporarily waiting next few days watch it extremely closely then entering unless it breaks through the bottom.
Feel free to do your DD on ABCL they actually have really good positive pipelines just being held down.
Bearish price action for the next several monthsAbcellera is undergoing a massive selloff in a zigzag pattern. Waves A and B are done, and wave C is usually 1.618 the length of wave A, especially since wave A is a leading diagonal. Expect further downside to the 6.30 region. Nevertheless, I do see a relief rally coming up soon, maybe around the 12.65 area.
